Dechert Re:Torts

Key Developments in Product Liability and Mass Torts

In this monthly newsletter you'll find insights and analysis covering significant legal trends, landmark cases, and strategic considerations for businesses facing complex litigation. It serves as a valuable tool for staying informed about the evolving landscape of tort law and its implications for various industries.

HOT TOPICS

PFAS Out, Libel In: Testing the Boundaries of Defamation and Tortious Interference

A turf manufacturer who recently developed a PFAS-free turf sues for defamation after an environmental organization makes a blanket statement that PFAS can be found in most artificial turfs.

Plaintiff-Side Firms Bear the Burdensome Costs of Third-Party Litigation Lending

Third-party litigation funding presents significant financial risks for attorneys due to burdensome loan terms and the protracted nature of mass tort litigation. 

A Class Act: Is England a New Battleground in High-Value Multi-Claimant Actions?

Multi-claimant litigation in England has surged since 2022, with significant increases in CAT actions and GLOs, driven by high-value claims in areas such as data breaches and ESG, while courts continue to refine procedural mechanisms to manage these complex cases. 

CLASS NOTES

The No-Harm Foul:  U.S. Supreme Court to Decide Whether Class Actions Can Include Uninjured Plaintiffs 

Supreme Court will clarify how standing factors into class certification. 

ENVIRONMENTAL EDIT

Environmental Group Sues FDA over Inaction on PFAS in Food

Plaintiffs seek to force the FDA to set limits on PFAS levels in food. 

JURISDICTIONAL JABBER

State Court Appeals to Watch in 2025

Appeals before the Washington Supreme Court in a PCB exposure case, the Supreme Court of California in litigation involving HIV medications, and the Supreme Court of Appeals of West Virginia in municipality cases against prescription opioid distributors are likely to have an impact beyond those actions.

EVENT

Life Sciences Day 2025

Join Dechert in Philadelphia on March 5 for 2025 Life Sciences Day, an interdisciplinary program designed for in-house counsel, chief officers, and strategic investors. This half-day CLE program offers a fantastic opportunity to connect with industry leaders and discuss the rapid changes affecting the sector. For more information and to register, click here.